Continuous Glucose Monitoring in Patients Undergoing Cardiopulmonary Bypass
Part of paid clinical trials in Winston-Salem, North Carolina.
- Sponsor
- Wake Forest University Health Sciences
- Study ID
- NCT06861881
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Glucose Metabolism Disorders (Including Diabetes Mellitus)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Dexcom G7 Continuous Glucose Monitor — DEVICEDexcom G7 continuous glucose monitor will be placed prior to cardiac surgery. It will be worn continuously throughout the perioperative period and during the time admitted to the Cardiovascular Intensive Care Unit.
Study Details
The purpose of this research study is to test the accuracy of the Dexcom continuous glucose monitoring device during the cardiothoracic surgical procedure and recovery period in the Cardiac Intensive Care Unit. Readings from the device will be compared with the standard of care blood glucose levels that are obtained during your surgery and postoperatively.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Jan 2026
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Experimental: Continuous Glucose MonitoringAll participants will wear the Dexcom G7 continuous glucose monitor continuously during their cardiothoracic surgery and throughout their time admitted to the Cardiovascular Intensive Care Unit.
Primary Outcome Measure
Continuous Glucose Monitoring Accuracy Compared to Point-of-Care Measurements [ Time Frame: Up to Day 10 ]
Central Contacts
- Megan H Hicks, MD336-716-4498
- Lynnette Harris, BSN RN336-716-8791
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | Megan Hicks, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Winston-Salem, NC
Related Studies
- Glucose Variability and Cognition in PrediabetesRecruiting · University of Maryland, Baltimore · Baltimore, Maryland
- A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusPHASE1/PHASE2 · Recruiting · Otsuka Pharmaceutical Factory, Inc. · Chicago, Illinois